Experimental study of the "'rebound syndrome" following discontinuation of prolonged phenazepam administration and possibilities for preventing it

Voronina, T.A.; Garibova, T.L.

Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 81(7): 1056-1059

1981


ISSN/ISBN: 0044-4588
PMID: 7197446
Document Number: 180933
Phenazepam given to rats in a daily dose of 2 mg/kg intraperitoneally for a long (30 days) time ceased to produce the sedative effect, and discontinuation of the medication led to development of the so-called "recoil syndrome" characterized by general depression and disturbances of the conditioned-reflex activity. The "recoil syndrome" was distinguished for a selective specificity, since its motor and sensor manifestations were eliminated only by benzodiazepine derivatives (phenazepam, diazepam). Drugs from other chemical slasses (meprobamate, trioxazine, amipazin) did not influence this syndrome.

Document emailed within 1 workday
Secure & encrypted payments